Page last updated: 2024-10-18

dimethyl sulfoxide and Encapsulating Peritoneal Sclerosis

dimethyl sulfoxide has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.

Research Excerpts

ExcerptRelevanceReference
" We demonstrated that dimethyl sulfoxide (DMSO) effectively inhibited autoimmune diabetes recurrence in the islet transplantation of NOD mice via the induction of the differentiation of Treg cells."3.91Adoptive transfer of DMSO-induced regulatory T cells exhibits a similar preventive effect compared to an in vivo DMSO treatment for chemical-induced experimental encapsulating peritoneal sclerosis in mice. ( Chang, HM; Chen, YW; Cheng, CP; Hong, ZJ; Huang, SH; Lin, GJ; Lin, JR; Liu, XD; Sytwu, HK; Wu, CH; Yu, CC, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, GJ1
Wu, CH1
Yu, CC1
Lin, JR1
Liu, XD1
Chen, YW1
Chang, HM1
Hong, ZJ1
Cheng, CP1
Sytwu, HK1
Huang, SH1

Other Studies

1 other study available for dimethyl sulfoxide and Encapsulating Peritoneal Sclerosis

ArticleYear
Adoptive transfer of DMSO-induced regulatory T cells exhibits a similar preventive effect compared to an in vivo DMSO treatment for chemical-induced experimental encapsulating peritoneal sclerosis in mice.
    Toxicology and applied pharmacology, 2019, 09-01, Volume: 378

    Topics: Adoptive Transfer; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Differentia

2019